Board Change

20th Nov 2026 07:00

RNS Number : 9567D
Fevara PLC
20 November 2026
 

 

20 November 2026

 

Fevara plc

 

(“Fevara” or the “Company”)

 

Board Change

 

Fevara plc (LSE: FVA), an international specialist in livestock supplements, announces that Gillian Watson, Senior Independent Non-Executive Director, has informed the Company that she will not seek re-election at the Company’s next Annual General Meeting (“AGM”), expected to be held in February 2027. Gillian will therefore retire from the Board at the conclusion of the AGM.

 

Tim Jones, Non-Executive Chair of Fevara, commented: “On behalf of the Board, I would like to thank Gillian for her support, counsel and contribution to Fevara since joining the Board in October 2023. I am enormously grateful for all she has brought to the Board, and she will be very much missed. We wish her every success for the future.”

 

Gillian Watson commented: “It has been a privilege to serve on the Board through a period of significant transition and stabilisation. Over the last three years, the Group has reshaped itself from Carr’s Group into Fevara, a focused international specialist in livestock supplements, and has returned to sustainable profit growth, with adjusted operating profit expected to have nearly tripled since my first full year on the Board. I have very much enjoyed working with Tim, my fellow directors and the executive team, and I leave knowing the business is well placed for its next phase of growth. I wish everyone at Fevara continued success.”

 

For further information, please contact:

 

Enquiries

 

 

 

Fevara plc

+44 (0) 1228 554 600

Joshua Hoopes, Chief Executive Officer

Gavin Manson, Chief Financial Officer

 

 

 

 

 

Hudson Sandler

+44 (0) 20 7796 4133

Wendy Baker / India Laidlaw / Henry Mathieu

 

 

 

 

About Fevara plc:

 

Fevara is an international specialist in livestock supplements.

 

Fevara’s purpose is to empower farmers in extensive grazing systems with research-proven products that boost profitability, improve resource efficiency and support sustainable agriculture. The Group develops, manufactures and markets research-proven supplements, including feed licks, blocks, bagged minerals, and boluses for cattle, sheep and horses, sold under recognised and trusted brands, including Crystalyx, Horslic, Horslyx, Scotmin Nutrition, SmartLic, Tracesure Advanced and Macal.

 

Headquartered in Carlisle, Cumbria, in the UK, Fevara has six operational sites in Brazil, UK and the USA, with three joint ventures in Germany, the UK and the USA. It serves customers in more than 20 countries through its expansive international distribution and support network.

 

Fevara has been listed on the London Stock Exchange since 1972. Fevara plc's ticker is "FVA".

 

For more information, visit: https://www.fevara.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAAKCBQOBDDPDD